Brain cancer classification based on multistage ensemble generative adversarial network and convolutional neural network

3Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

An advanced approach that capitalizes on the synergies between multimodal feature fusion and the dual-path network is presented in this manuscript. Our proposed methodology harnesses a combination of potent techniques, merging the benefits of nonlinear mapping and expansive perception. The foundation of our methodology lies in leveraging well-established pretrained models, namely EfficientNet-B7, ResNet-152, and a meticulously crafted custom convolutional neural network (CNN), to effectively extract salient features from the data. These models are combined in a two-stage ensemble approach. We employ maximum variance unfolding (MVU) to select the most relevant attributes from the extracted features. In this study, we propose a hybrid approach that integrates a generative adversarial network and Neural Autoregressive Distribution Estimation (NADE-K) with a CNN. The resulting two-stage ensemble hybrid CNN model achieves an accuracy of 99.63%. The implementation of the two-stage ensemble hybrid CNN with MVU demonstrates significant improvements in brain tumor classification.

Cite

CITATION STYLE

APA

Melekoodappattu, J. G., Kandambeth Puthiyapurayil, C., Vylala, A., & Sahaya Dhas, A. (2023). Brain cancer classification based on multistage ensemble generative adversarial network and convolutional neural network. Cell Biochemistry and Function, 41(8), 1357–1369. https://doi.org/10.1002/cbf.3870

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free